Dialectical behavioral therapy (DBT) in borderline personality disorder - early assessment briefs (Alert)
Swedish Council on Technology Assessment in Health Care
Record ID 32006000015
Swedish
Authors' objectives:
This review aims to assess the effectiveness of dialectical behavioral therapy (DBT) in borderline personality disorder.
Authors' results and conclusions:
Patient benefit: Six randomized controlled trials compared DBT to other psychiatric treatment. A large percentage of women were included in these trials. The duration of treatment was usually 1 year, and the outcomes varied by study, partly because different subgroups were studied. The results show that DBT leads to a reduction in self-injurious behavior and fewer dropouts from treatment. The effects were found to remain in followup for up to 2 years. Treatment also appeared to reduce the need for hospitalization and reduce drug use among substance abusers. There is no evidence to show that treatment outcomes would be influenced in patients who are also diagnosed with substance abuse. Likewise, there are no confirmed results concerning the impact of different treatment components on the outcome.
Authors' recommendations:
There is limited scientific evidence showing that DBT reduces self-injurious behavior and that the effect remains at 2-year followup (Evidence grade 3). Treatment also appears to reduce the need for hospitalization and reduce drug use among people with addictions. Hence, DBT appears to be a promising form of treatment for patients with borderline personality disorder. However, it needs to be tested under Swedish conditions, and it is essential to conduct studies addressing the cost effectiveness of the method.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.sbu.se/Published
Year Published:
2005
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Sweden
MeSH Terms
- Behavior Therapy
- Borderline Personality Disorder
Contact
Organisation Name:
Swedish Agency for Health Technology Assessment and Assessment of Social Services
Contact Address:
P.O. Box 3657, SE-103 59 Stockholm, Sweden. Tel: +46 8 4123200, Fax: +46 8 4113260
Contact Name:
registrator@sbu.se
Contact Email:
registrator@sbu.se
Copyright:
Swedish Council on Technology Assessment in Health Care (SBU)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.